{
  "package" : "hl7.terminology.r5@6.3.0",
  "definition" : "Substitution occurred or is permitted with another product having the same therapeutic objective and safety profile.\\r\\n\\r\\n*Examples:* \\r\\n\\r\\n *  ranitidine for Tagamet",
  "system" : "http://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitution",
  "property" : [ {
    "code" : "status",
    "valueCode" : "active"
  }, {
    "code" : "internalId",
    "valueCode" : "16624"
  }, {
    "_uri" : "http://hl7.org/fhir/concept-properties#parent",
    "code" : "parent",
    "_implicit" : true,
    "valueCode" : "E"
  }, {
    "_uri" : "http://hl7.org/fhir/concept-properties#child",
    "code" : "child",
    "_implicit" : true,
    "valueCode" : "TB"
  }, {
    "_uri" : "http://hl7.org/fhir/concept-properties#child",
    "code" : "child",
    "_implicit" : true,
    "valueCode" : "TG"
  } ],
  "codesystem" : "4b53ad0c-9eb4-59e5-bfa0-ab2824570ae7",
  "concept_id" : "ce7f31ef-7226-5c35-8c2e-11b35d5e3d4a",
  "ancestors" : {
    "E" : 1,
    "TE" : 0,
    "_ActSubstanceAdminSubstitutionCode" : 2
  },
  "id" : "38ef3b1c-f16a-470a-b1ba-9130c504815a",
  "code" : "TE",
  "display" : "therapeutic alternative",
  "version" : "3.0.0"
}